Vasomotor Rhinitis Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 4 Weeks in Adult and Adolescent Subjects (12 Years of Age and Older) With Vasomotor Rhinitis
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with vasomotor rhinitis (VMR).
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00979615 -
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
|
Phase 4 | |
| Completed |
NCT01509209 -
Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis
|
Phase 3 | |
| Completed |
NCT00745849 -
Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial
|
N/A | |
| Recruiting |
NCT05348148 -
Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis
|
N/A | |
| Completed |
NCT00682162 -
Impact of Acupuncture on Vasomotor Rhinitis
|
Phase 3 | |
| Completed |
NCT00415493 -
Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation
|
N/A | |
| Completed |
NCT00976209 -
Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
|
Phase 3 |